The aim of this study was to evaluate the prevalence of cancer testis tumor-associated antigens MAGE-A and NY-ESO-1 in cervical cancer and correlate expression patterns with clinicopathologic parameters and prognosis.
MAGE-A and NY-ESO-1 expression in cervical cancer: investigation on prognostic factors and effect of chemotherapy / Napoletano, C., Bellati, F., Tarquini, E., Tomao, F., Taurino, F., Spagnoli, G., Rughetti, A., Muzii, L., Nuti, M., BENEDETTI PANICI, P.. - In: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. - ISSN 0002-9378. - STAMPA. - 198:1(2008), pp. 99.e1-99.e7. [10.1016/j.ajog.2007.05.019]
MAGE-A and NY-ESO-1 expression in cervical cancer: investigation on prognostic factors and effect of chemotherapy
NAPOLETANO, Chiara;BELLATI, FILIPPO;TOMAO, FEDERICA;RUGHETTI, Aurelia;MUZII, LUDOVICO;NUTI, Marianna;BENEDETTI PANICI, PIERLUIGI
2008
Abstract
The aim of this study was to evaluate the prevalence of cancer testis tumor-associated antigens MAGE-A and NY-ESO-1 in cervical cancer and correlate expression patterns with clinicopathologic parameters and prognosis.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
